difference between urine and blood Pco, was found after bicarbonate administration. This acidification defect can best be explained as an abnormality in distal tubular H+ secretion: a rate-dependent distal tubular acidosis. It is speculated that long-chain acylcarnitines, substances that cannot be formed by carnitine palmitoyltransferase I-deficient patients, play an essential role in renal acid-base homeostasis. (Pediatr Res 36: [582] [583] [584] [585] [586] [587] [588] 1994) Abbreviations CPT, carnitine palmitoyltransferase LCT, long-chain triglyceride MCT, medium-chain triglyceride RTA, renal tubular acidosis dRTA, distal renal tubular acidosis (U-B)Pco,, difference between urine and blood carbon dioxide pressure Mitochondria1 fatty acid oxidation disorders are increasingly being recognized as an important group of inborn errors of metabolism that can cause energy deprivation at times of stress, prolonged fasting, or exercise.
Thus far, 13 different enzyme defects have been identified. The presenting symptoms are highly variable and the clinical and biochemical characteristics only rarely permit a specific diagnosis in the absence of a direct enzyme analysis method.
For the transport of long-chain fatty acids across the mitochondrial membrane, before they undergo p-oxidation in the mitochondrial matrix, carnitine palmitoyltransferases (CPT I and CPT 11) and the carnitineacylcarnitine translocase are required. CPT I, located on the inner side of the outer mitochondrial membrane, catalyzes the formation of fatty acylcarnitines from acylCoA and carnitine (1) . Acylcarnitine is transferred across the inner mitochondrial membrane in exchange for carnitine by carnitine acyl-carnitine translocase (2) . Longchain acyl-CoA esters are generated inside the mitochondrion by the action of CPT 11.
Patients with CPT I deficiency suffer from recurrent episodes of hypoketotic hypoglycemia characterized by decreased levels of consciousness, hepatomegaly, and hepatic dysfunction. Usually the patients are symptom free when their mitochondrial fatty acid oxidation system is not stressed.
CPT I deficiency was first described in 1981 (3) in a patient with severe hypoketotic hypoglycemia without dicarboxylic aciduria. Since then, only nine patients have been reported in the literature (4) (5) (6) (7) (8) (9) (10) (11) . More recently, 583 centrations, and persistent mild metabolic acidosis. Extensive renal function tests showed a distal tubular H+ transport defect, which stresses the necessity of renal evaluation in the workup of patients with CPT I deficiency.
CASE REPORT
A girl was born to unrelated, healthy Dutch parents after a normal pregnancy and delivery. Birth weight was 3530 g. After 2 uneventful days, vomiting, increasing lethargy, transient cardiac arrhythmia, and a respiratory arrest developed, requiring mechanical ventilatory support for 2 d. Antibiotics were given for suspected septicemia. At that time, the following blood laboratory values were recorded: glucose 1.6 mmol/L (normal 2.8-5.6 mmol/L), capillary pH 7.33, Pco, 50 mm Hg, base excess -0.4 mmol/L, Po, 49 mm Hg, alanine aminotransferase 78 U/L (normal 3-47 U/L), aspartate aminotransferase 105 U/L (normal 7-43 U/L), sodium ions 139 mmol/L (normal 135-148 mmol/L), and potassium ions 7.3 mmol/L (normal 4.1-5.3 mmol/L). All bacterial and viral cultures remained negative. A complete recovery was obtained after 9 d of symptomatic therapy, and no explanation for the high potassium was found. A cardiac ultrasound examination showed no abnormalities.
Between the age of 6 mo and 3 y, the patient presented nine episodes of a Reye-like syndrome, often preceded by a mild upper respiratory tract infection. These episodes were marked by lethargy, hepatomegaly, and the following laboratory data: blood ammonia 52-145 kmol/L (normal 55-90 kmol/L), aspartate aminotransferase 20-600 U/L, alanine aminotransferase 25-600 U/L, capillary pH 7.27-7.37, and base excess -3.0-0.1. Hypoglycemia was never detected. A liver biopsy at the age of 10 mo revealed massive macrovesicular and microvesicular steatosis with a normal amount of glycogen. The urinary excretion of dicarboxylic acids was slightly increased during one episode (3-OH-butyric acid 40 pmol/L, adipic acid 221 kmol/L, 3-OH-adipic acid 415 kmol/L, unsaturated suberic acid 116 pmol/L, suberic acid 123 kmol/L, sebacic acid 373 kmol/L, 3-OH-sebacic acid 252 p,mol/L, dodecanedioic acid 300 pmol/L, and 3-OH-dodecanedioic acid 66 pmol/L). Plasma concentrations of free carnitine were within the normal range or moderately increased on several occasions (51,58,59, and 63 kmol/L at 2 and 3 y; normal values 47 2 7.0 p,mol/L). At each episode, there was a rapid improvement of the lethargy upon the administration of parenteral glucose, and the transaminases returned to normal within 2 to 4 wk depending on the severity of the decompensation.
An LCT loading test performed at the age of 18 mo showed no increase of the plasma ketones, in contrast to the brisk rise in plasma ketones during the MCT loading test. After the latter test, the patient was put on an MCT-enriched diet, and the parents were instructed to prevent a fasting period longer than 12 h. As a result of this regimen, the frequency of hospitalization became less during episodes of vomiting associated with a mild infection. Although her plasma glucose was never below 3 mmol/L, she always recovered quickly after i.v. infusion of glucose.
At the age of 3 y, her mental and motor development were normal. Her length was 95 cm (50th percentile), weight 13.6 kg (30th percentile), and head circumference 48 cm (50th percentile). Between the acute episodes, her liver was normal in size and function. However, a mild persistent metabolic acidosis was noted. The patient required daily oral supplementation of 4 mmol of sodium bicarbonate per kg to maintain serum bicarbonate concentrations between 19 and 21 mmol/L.
Renal function tests were performed at the age of 3 y, after parental informed consent for studies had been obtained.
METHODS

Metabolic Investigations
LCT and MCT loading tests were performed to test the long-chain and medium-chain fatty acid oxidation in vivo. After a 10-h overnight fast, LCT (sunflower oil; 1.5 g/kg) or MCT (1.5 g/kg) were administered orally. The plasma concentrations of glucose, FFA, P-hydroxybutyrate, and acetoacetate were determined at 0, 1, 2, and 3 h after the load by routine clinical chemical methods.
Organic acids in plasma (12) and urine (13) were determined by gas chromatography/mass spectrometry. Total and free plasma and urinary carnitine were measured by a spectrophotometric method using dithio-bis-nitrobenzoic acid (14) . Plasma was deproteinized using Amicon CF50 Centriflo ultrafiltration membrane cones (Amicon Corp., Danvers, MA).
Studies of 14c-labeled fatty acid oxidation were performed in intact cultured skin fibroblasts as previously described (8). The activities of mitochondria1 long-chain, medium-chain, and short-chain acyl-CoA dehydrogenases were measured in fibroblasts using the electrontransferring flavoprotein reduction assay (15) . The CPT I and CPT I1 activities were determined in fibroblasts as previously described (5, 8) .
Renal Investigations
Renal function tests were performed over a 2-d period, after cessation of the bicarbonate supplementation for 3 d. Two needles were placed into peripheral veins, one for the infusion of the test substances and one for the repeated blood sampling. Urine was collected by an indwelling urinary catheter.
The glomerular filtration rate was determined during continuous infusion of inulin and timed collections of urine and plasma samples by following standard methods (16) . Inulin was measured by the anthrone method (16) . Simultaneously, the clearance of endogenous (free and acyl) carnitine was measured.
Acid challenge test. Urinary acidification and acid excretion were assessed after i.v. administration of arginine hydrochloride (150 mmol/m2 body surface area as a 10%
1.5 solution) as described by Loney et al. (17) . Blood samples were analyzed for inulin, pH, and bicarbonate con-, cl centration, and urine samples for volume, pH, titratable g acid, NH,+, and inulin. After arginine hydrochloride ad-5 1 ministration, acidosis was corrected by overnight admin-LI =;
istration of 30 mmol of sodium bicarbonate i.v.
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Bicarbonate loading. The following morning, 20 mmol E of sodium bicarbonate was infused in 1 h to obtain max-0.5 imal alkalinized urine. During this period and during the following hour, urine samples were collected in 30-min periods, and capillary blood samples were obtained at 1 and 2 h after the start of the sodium bicarbonate infusion.
In all urine and blood samples, pH, Pco,, creatinine, and bicarbonate concentration were determined; urine volumes were also measured.
Distal tubular hydrogen ion secretion was assessed by calculation of the (U-B)Pco, after maximal alkalinization of the urine was obtained. Simultaneous measurements of the clearance of creatinine and bicarbonate allowed calculation of tubular reabsorption and fractional excretion of bicarbonate.
Renal handling of carnitine was assessed as described by Engel et al. (18) . After an overnight fast, hydration was provided by oral administration of 15 mL of water per kg. After a bolus injection of inulin of 50 mglkg, infusion of 25 mg-m-2-min-1 was continued for 250 min. Forty-five min after the start of the inulin infusion, L-carnitine was infused at a constant rate of 0.25 pmol/min/kg for 205 min. Urine samples were collected at 30-min intervals, and plasma samples were obtained at the midpoint of each urine collection for determination of total and free carnitine and inulin. Rates of filtration and excretion of carnitine are expressed as pmo1/100 mL glomerular filtrate. Reabsorption of carnitine was calculated from the difference between filtration and excretion. The fractional excretion of filtered carnitine was calculated by the following formula: Ucarnitine x Pinulin/Pcarnitine x Uinulin x 100, where U is urine and P is plasma.
RESULTS
Metabolic Investigations
The plasma total carnitine was in the high-normal range (mean 61 pmol/L; control <65 pmol/L).
The urinary excretion of dicarboxylic acids was slightly increased during one episode of decompensation; the profile was dominated by dodecanedioate (300 pmol/ L). Plasma organic acid analysis did not reveal the presence of unusual substances such as decenoic acid or 3-hydroxy-fatty acids.
The response of total plasma ketone bodies during in vivo loading with LCT or MCT is shown in Figure 1 . Values of plasma ketone bodies remained inappropriately low after the LCT loading (P-hydroxybutyrate 0.096 mmol/L, acetoacetate 0.038 mmol/L), indicating a defect in the hepatic long-chain fatty acid oxidation. In contrast, plasma ketones rose rapidly (P-hydroxybutyrate from 0.056 to 0.802 mmol/L and acetoacetate from 0.023 to 0.463 mmol/L) after the MCT loading. The blood glucose levels as well as the urinary organic acids remained normal throughout both loading tests. The activity of CPT I in the patient's skin fibroblasts was significantly decreased (17% of mean control values; Table 1 ); CPT I1 activity was normal. Both medium-chain and short-chain fatty acids were oxidized normally, whereas the rate of long-chain fatty acid oxidation in the patient's fibroblasts was very low compared with that of control subjects ( Table 1) . Activities of long-chain, medium-chain, and short-chain acyl-CoA dehydrogenases were normal (data not shown). 
Renal Investigations (4). Blood glucose values during decompensation report-
The glomerular filtration rate was within the normal range (106 mWminl1.73 m2; range 100-115 mWrninl1.73 m2).
Acid challenge test. After the discontinuation of the sodium bicarbonate supplementation, the patient developed a spontaneous acidosis (pH 7.31). During acidosis, urinary pH remained relatively high (6.8). Acidosis persisted despite quantitative important ammonium excretion (81 kEqlminl1.73 m2) as shown in Table 2 . After loading with arginine hydrochloride, the urinary pH decreased to 4.7 with an increased acid excretion (179 yEqlminll.73 m2). The titratable acid was 70 and the NH,+ was 108 kEqlminl1.73 m2.
Bicarbonate loading. During sodium bicarbonate loading, with serum bicarbonate increasing from 17 to 23 mmolIL, the excretion of bicarbonate remained stable at 2% of the filtered load. The plasma Pco, was 40 mm Hg, and the urinary Pco, was 34 mm Hg after bicarbonate loading. The (U-B)Pco, during maximal alkalinization of the urine (pH = 8.1) was -6 (normal 19 + 10).
Evaluation of the fractional excretion and reabsorption of carnitine showed a low fractional excretion of free (1.26%) and esterified (3.32%) carnitine when measured at basal endogenous free (51 kmolIL; Table 3 ) and esterified (14 p.mol/L) plasma carnitine concentrations. A high plasma threshold value, taking a value of 5% as the upper limit of normal for fractional free carnitine excretion, for free carnitine of 60 pmol1L (normal 46 & 7.0 kmol1L) and normal tubular reabsorption of 6.40 pmo1/100 mL glomerular filtrate (normal 7.2 2 0.4 pmo1/100 mL) were found (Table 3) .
DISCUSSION
CPT I deficiency has been described in 10 patients (Table 3) . The clinical presentation is characterized by recurrent episodes of hypoketotic hypoglycemia and relatively normal urinary organic acid excretion.
The CPT I activity measured in fibroblasts of our patient (17%) was in the same range as the CPT I activity of other patients (10-23%) reported in the literature. The age of onset of the initial symptoms in patients with CPT I deficiency varied between birth and 33 mo ( Table 4) . The most persistent clinical finding was hepatomegaly found at the time of a decompensation, which was found in all reported cases except in the patient of Tein et al.
edly ranged between 0.55 mmol1L and normal. In followup, the patients often had a number of episodes of hypoglycemia and lethargy associated with intercurrent illness requiring hospitalization and parenteral glucose (4-6, 9-11). Bonnefont et al. (6) reported that these episodes decreased with age, which was also the case for our patient. There appeared to be no correlation between the age of onset or the severity of the clinical presentation and the degree of CPT I deficiency.
In our patient, hypoglycemia could only be found during the initial episode in the neonatal period. However, during the other nine episodes, glucose administration was followed by a quick recovery, probably reflecting low intracellular glucose concentration. One described patient with a CPT I deficiency never had documented periods of hypoglycemia, but died 11 d after she had been admitted to hospital in a coma (8).
The presence of a mild, nonspecific dicarboxylic aciduria in the acute episode was initially thought to suggest an intramitochondrial fatty acid oxidation defect. Increased dicarboxylic aciduria is generally not a feature of CPT I deficiency (9) . Only once has a slightly increased urinary dicarboxylic acid profile been reported (Table 3;  10) . Saturated C,, dicarboxylic acid as the major component in the dicarboxylic acid profile has also been observed in a patient with hepatic CPT I1 deficiency shortly before the patient died (Pollitt R., personal communication).
Decreased concentrations of plasma carnitine and increases in the esterified fraction of carnitine have been associated with many defects in fatty acid metabolism, including the severe form of CPT I1 deficiency and deficiency of the carnitine-acylcarnitine translocase (2, 19) . The exception to this rule are patients with a CPT I deficiency in whom the total plasma carnitine concentration is in the high-normal range (Table 4 ). The total and free plasma carnitine concentrations of our patient were 51 and 20 kmol/L 3 d after an acute episode, and after recuperation free carnitine was slightly increased (51-63 pmol1L). Renal carnitine handling in this patient was normal except for the elevated threshold of free carnitine reabsorption (60 kmol1L). The inability to form longchain acylcarnitines in CPT I deficiency and the knowledge that long-chain acylcarnitines are potent inhibitors of free carnitine transport (20, 21) explain an apparently t kmol 100 mL glomerular filtrate-'.
$ Fractional excretion % UCarnitine X Pinulin/Pcarnitinc X Uinulin X 100.
5 Infusion of L-carnitine 0.25 pmol . min-' -kg-' for 200 min.
higher renal threshold for free carnitine. In this view, high-normal-to-increased plasma carnitine values could be the first clue in distinguishing CPT I deficiency from other mitochondria1 fatty acid oxidation disorders (9) . Although both palmitoyl-CoA (the accumulated product in CPT I deficiency) and palmitoylcarnitine (the accumulated product in CPT I1 deficiency) have been implicated in damaging the in vitro cardiac models (22, 23) , only palmitoyl-CoA can leave the liver cell and thereby damage the cardiac muscle; palmitoylcarnitine is unable to leave the liver cell. This is an argument for the absence of a myocardial involvement in CPT I deficiency. Another hypothesis for the lack of cardiac involvement in the classic "hepatic" form of CPT I deficiency would be the presence of tissue-specific isoforms of the CPT I enzyme. The classic hepatic form of CPT I deficiency is expressed in cultured skin fibroblasts and liver but not in muscle (4) . Data obtained in rat and mouse suggest the presence of distinct CPT I isoforms in the liver, skeletal muscle, and heart (24) .
RTA in association with defects of fatty acid oxidation has rarely been reported. Detailed information about the renal function in CPT I deficiency has been reported only in one case in which distal tubular acidosis was suggested based on a decreased (U-B)Pco, (10) . The persistence of the metabolic acidosis in our patient led us to perform extensive renal function tests.
RTA is a condition characterized by tubular insufficiency either in the renal reabsorption of bicarbonate (proximal RTA), the excretion of hydrogen ion (dRTA), or both (25) .
In our patient, urinary H+ excretion was insufficient to maintain the blood pH within the normal range, resulting in acidosis after discontinuation of the daily bicarbonate supplementation. The urinary pH was insufficiently lowered in relation to the low serum bicarbonate. During bicarbonate loading, urinary bicarbonate excretion at low and normal plasma bicarbonate values was less than 5%, suggesting the diagnosis of dRTA.
During acid loading, urinary pH decreased normally and total acid excretion increased. Having taken into account the chronic acid load, urinary NH,+ excretion remained relatively low ( Table 2 ). The excretion of acid urine excludes the diagnosis of classic dRTA.
The measurement of the urinary PCO, in alkaline urine is a different method for evaluating H+ secretion by the distal nephron (26) . When the distal nephron is flooded with bicarbonate-containing fluid, hydrogen ions that are excreted into the distal nephron and collecting duct neutralize bicarbonate, thereby forming carbonic acid (H2C03). The dissociation of H2C03 into H,O and CO, progresses slowly, because there is no carbonic anhydrase present in the lumen of the distal nephron. The diffusion of CO, out of the tubular fluid being restricted, the (U-B)Pco2 gradient reflects distal tubular H+ secretion (27) .
The low (U-B)Pco, found in this patient (-6 ) is in concordance with the findings of Falik-Borenstein et al. (10) and reflects a dysfunction in tubular H+ secretion. In our opinion, this condition could best be described as (H+ secretion) rate-dependent dRTA (28) .
The occurrence of such a disorder of acid-base homeostasis in at least two patients with CPT I deficiency suggests a relationship between the two phenomena. It is tempting to assume a role for long-chain acylcarnitines in this respect. These substances may influence the renal handling of free carnitine (9). It is not known whether the primarily proximal renal tubular reabsorption of free carnitine interferes with the proximal tubular ammonium production and hence acid excretion. However, this does not explain the defect in distal tubular hydrogen excretion. Another possible "nonspecific" mechanism to be considered for the rate-dependent dRTA would be a defect in energy metabolism in the kidney due to deficiency of the renal CPT I isoform, because fatty acid oxidation is thought to be an important source of energy in the kidney. In the CPT I deficiency case described by Falik-Borenstein et al. (lo) , the administration of MCT to a CPT I-deficient patient led to the complete resolution of the RTA.
Many additional in vivo and in vitro experiments will be needed, such as cautious administration of small amounts of long-chain acylcarnitines under close medical supervision to CPT I-deficient patients or preferably an in vitro 
